0002110597-26-000002.txt : 20261006 0002110597-26-000002.hdr.sgml : 20261006 20261006105716 ACCESSION NUMBER: 0002110597-26-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261006 DATE AS OF CHANGE: 20261006 EFFECTIVENESS DATE: 20261006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fairfield Bio, Inc. CENTRAL INDEX KEY: 0002110597 ORGANIZATION NAME: EIN: 395159154 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-573452 FILM NUMBER: 261442707 BUSINESS ADDRESS: STREET 1: 5454 PALISADE AVENUE CITY: BRONX STATE: NY ZIP: 10471 BUSINESS PHONE: 6467094770 MAIL ADDRESS: STREET 1: 5454 PALISADE AVENUE CITY: BRONX STATE: NY ZIP: 10471 D/A 1 primary_doc.xml X0708 D/A LIVE 0002110597 Fairfield Bio, Inc. 5454 PALISADE AVENUE BRONX NY NEW YORK 10471 6467094770 DELAWARE None None Corporation true 2025 Kevin Slavin c/o Fairfield Bio, Inc. 5454 Palisade Avenue Bronx NY NEW YORK 10471 Executive Officer Director Mitchell Wolfe c/o Fairfield Bio, Inc. 5454 Palisade Avenue Bronx NY NEW YORK 10471 Executive Officer Director Other Decline to Disclose 06b true 0002110597-26-000001 2026-01-26 false true false 0 3000000 1945000 1055000 false 11 0 0 350000 This is an estimate of the gross proceeds of the offering that will be paid out to officers and managers over the following 12 months if no other monies are earned by the company. false Fairfield Bio, Inc. Kevin Slavin Kevin Slavin President 2026-10-06